Clinical Trials List
2025-09-01 - 2033-05-31
Phase III
Recruiting6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Yuh-Min Chen Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林建佑 Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- 蔡政軒 Division of General Internal Medicine
- Chin-Wei Kuo Division of General Internal Medicine
- Seu-Chun Yang Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Chian-Wei Chen Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Yu-Min Yeh Division of General Internal Medicine
- Chun-Hui Lee Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李柏昕 Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳正雄 Division of General Internal Medicine
- 林明泰 Division of General Internal Medicine
- 林慶雄 Division of General Internal Medicine
- 施穎銘 Division of General Internal Medicine
- 林俊維 Division of General Internal Medicine
- 張時榮 Division of General Internal Medicine
- 黃國揚 Division of General Internal Medicine
- 蔡偉宏 Division of General Internal Medicine
- 葉金水 Division of General Internal Medicine
- 紀炳銓 Division of General Internal Medicine
- 詹博強 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭家佑 Division of General Internal Medicine
- Inn-Wen Chong Division of General Internal Medicine
- 李玫萱 Division of General Internal Medicine
- Ying-Ming Tsai Tsai Division of General Internal Medicine
- 莊政皓 Division of General Internal Medicine
- Chih-Jen Yang Division of General Internal Medicine
- 李岱晃 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖斌志 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- Jih-Hsiang Lee Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- James Chih-Hsin Yang Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 徐偉勛 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- Chia-Chi Lin Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
680 participants
